ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
61,620.93
1.35%
S&P 500
5,222.68
0.16%
Dow Jones
39,512.84
0.32%
US Dollar vs Yen
155.775
0.00%
Brent Oil
82.585
0.00%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. AbSci Corporation (ABSI)

  7. AbSci Corporation (ABSI) ニュース

ABSI

AbSci (ABSI)

AbSci Corporation
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:ABSI
日付受信時刻ニュースソース見出しコード企業名
2024/04/1621 : 00GlobeNewswire Inc.Absci to Report Business Updates and First Quarter 2024 Financial and Operating Results on May 14, 2024NASDAQ:ABSIAbSci Corporation
2024/03/2905 : 05GlobeNewswire Inc.Absci to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:ABSIAbSci Corporation
2024/03/2120 : 30GlobeNewswire Inc.Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating ResultsNASDAQ:ABSIAbSci Corporation
2024/03/0206 : 01GlobeNewswire Inc.Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters’ Option to Purchase Additional SharesNASDAQ:ABSIAbSci Corporation
2024/02/2906 : 06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABSIAbSci Corporation
2024/02/2822 : 34Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ABSIAbSci Corporation
2024/02/2812 : 20GlobeNewswire Inc.Absci Announces Pricing of Public Offering of Common StockNASDAQ:ABSIAbSci Corporation
2024/02/2806 : 45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABSIAbSci Corporation
2024/02/2806 : 40Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ABSIAbSci Corporation
2024/02/2806 : 01GlobeNewswire Inc.Absci Announces Proposed Public Offering of Common StockNASDAQ:ABSIAbSci Corporation
2024/02/2121 : 30GlobeNewswire Inc.Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AINASDAQ:ABSIAbSci Corporation
2024/02/2022 : 00GlobeNewswire Inc.Absci to Participate in Upcoming Investor ConferencesNASDAQ:ABSIAbSci Corporation
2024/02/1408 : 16Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ABSIAbSci Corporation
2024/02/0609 : 14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABSIAbSci Corporation
2024/02/0609 : 14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABSIAbSci Corporation
2024/02/0609 : 12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABSIAbSci Corporation
2024/02/0609 : 09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABSIAbSci Corporation
2024/01/1021 : 30GlobeNewswire Inc.Absci Appoints Professor Sir Mene Pangalos to its Board of DirectorsNASDAQ:ABSIAbSci Corporation
2024/01/0821 : 08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABSIAbSci Corporation
2024/01/0821 : 00GlobeNewswire Inc.Absci to Present Preclinical Data for ABS-101, A Potential Best-in-Class Anti-TL1A Antibody Development Program, at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:ABSIAbSci Corporation
2024/01/0506 : 58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABSIAbSci Corporation
2024/01/0506 : 57Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ABSIAbSci Corporation
2024/01/0322 : 00GlobeNewswire Inc.Absci to Participate in the 26th Annual Needham Growth ConferenceNASDAQ:ABSIAbSci Corporation
2023/12/2822 : 00GlobeNewswire Inc.Absci to Participate in the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:ABSIAbSci Corporation
2023/12/2022 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABSIAbSci Corporation
2023/12/2021 : 30GlobeNewswire Inc.Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug PipelineNASDAQ:ABSIAbSci Corporation
2023/12/0722 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABSIAbSci Corporation
2023/12/0500 : 41Dow Jones NewsAbsci Shares Rise 27% After Announcing Collaboration With AstraZenecaNASDAQ:ABSIAbSci Corporation
2023/12/0421 : 31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABSIAbSci Corporation
2023/12/0421 : 30GlobeNewswire Inc.Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology CandidateNASDAQ:ABSIAbSci Corporation
 Showing the most relevant articles for your search:NASDAQ:ABSI

最近閲覧した銘柄

USOTC
BASFY
BASF (QX)
FX
USDEUR
US Dollar vs Euro
NYSE
XOM
Exxon Mobil
NASDAQ
MSFT
Microsoft
CCOM
US30
US 30
NYSE
MRK
Merck
COIN
ETHUSD
Ethereum
AMEX
SPY
SPDR S&P 500
CCOM
SILVER
SILVER
NASDAQ
AAPL
Apple
NYSE
CVX
Chevron
USOTC
RHHBY
Roche (QX)
USOTC
BNPQY
BNP Paribas (QX)
AMEX
XLF
Financial Select Sector
NYSE
VZ
Verizon Communications
AMEX
XLV
Health Care Select Sector
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有